Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Remedies

NeurogesX Announces New PDUFA Date For Qutenza(TM) New Drug Application
NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced that the United States Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date from August 16, 2009 to November 16, 2009 to review the new drug application (NDA) for Qutenza(TM) to manage pain associated with postherpetic neuralgia (PHN).
generic viagra online
German Researchers Find There Is More To Bats' Vision Than Meets The Eye
The eyes of nocturnal bats possess two spectral cone photoreceptor types
News of the day
Programming Tools Facilitate Use Of Video Game Processors For Defense Needs
Video gaming computers and video game consoles available today typically contain a graphics processing unit (GPU), which is very efficient at manipulating and displaying computer graphics. However, the unit"s highly parallel structure also makes it more efficient than a general-purpose central processing unit for a range of complex calculations important to defense applications.
Sexual Health

Circulite(R) Synergy(R) Pocket Circulatory Assist Device To Be Featured At ASAIO And PEDS Conference

CircuLite®, Inc. will be participating at the 2009 American Society for Artificial Internal Organs (ASAIO) conference in conjunction with the 5th International Conference on Pediatric Mechanical Circulatory Support Systems & Pediatric Cardiopulmonary Perfusion (PEDS) held May 28 - 30, 2009 in Dallas, with a booth display featuring it"s Synergy® Pocket Circulatory Assist Device. Synergy is the first micro-pump designed for long-term, partial circulatory support to improve the quality of life for a broad range of chronic heart failure patients. Company representatives will be available at booth #115 to demonstrate and answer questions about the Synergy technology. Receive the latest updates from the ongoing long-term CE Mark trial for Synergy Meet members from CircuLite"s management team About Synergy® The Synergy® Pocket Micro-pump represents a new approach to mechanical circulatory support that can transform chronic heart failure management by providing a less-invasive, elective treatment option for patients before their disease state becomes emergent. Synergy is the first implantable system designed to provide partial circulatory support (PCS) for long-term use in millions of unserved patients that have NYHA Class IIIb/early IV disease. CircuLite"s patented micro-pump provides up to 3L/min of flow, which increases total cardiac output, offloads the heart, allowing it to rest, and potentially enables beneficial recovery of heart function. The size of a AA battery, the device is small enough to be implanted subcutaneously in a "pacemaker-like" pocket through a minimally-invasive procedure. CircuLite®


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009